The largest database of trusted experimental protocols

Anti lyve 1 antibody

Manufactured by Abcam
Sourced in United States, United Kingdom

Anti-LYVE-1 antibody is a laboratory reagent used to detect and study the LYVE-1 protein, which is a cell surface receptor involved in lymphatic vessel development and function. This antibody can be used in various immunological techniques, such as Western blotting, immunohistochemistry, and flow cytometry, to identify and analyze the LYVE-1 protein in biological samples.

Automatically generated - may contain errors

12 protocols using anti lyve 1 antibody

1

Corneal Flat-Mount Immunostaining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Corneal flat-mount immunostaining was performed as previously described.16 (link) Briefly, enucleated eyes were fixed in 4% PFA for 20 minutes at 4°C to avoid overfixation of the cornea, rinsed in PBS, and cut in half. Following removal of the extra tissues including lens and iris, the cornea was cut radially to facilitate flat mounting.
For flat-mount immunostaining to detect blood and lymphatic vessels, the corneas were placed in −20°C 100% methanol for 30 minutes and permeabilized with PBS/1% Triton X-100 for 20 minutes at 4°C, and blocked with 5% donkey serum (Sigma-Aldrich Corp.) for 20 minutes, and then stained with anti-Lyve-1 antibodies (Abcam, Cambridge, MA, USA) overnight at 4°C. Corneas were then washed with PBS/0.1% Tween 20 and then stained with PE-conjugated anti-CD31 (BD Biosciences Phamingen, San Diego, CA, USA; clone MEC 13.3) and AlexaFluor488 donkey anti-rabbit IgG (Invitrogen). Corneas were flat mounted and images were recorded on a Zeiss Axio Observer D1.
+ Open protocol
+ Expand
2

Preclinical Evaluation of circEHBP1 in Bladder Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies were carried out according to our previously published guidelines42 (link) and permitted by Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Nude BALB/c mice at 4 to 5 weeks old were obtained from the Experimental Animal Center (Guangzhou, P.R. China). The mice were divided randomly into groups, and 5 × 106 UM-UC-3 cells transfected with circEHBP1-overexpressing vector or negative control (NC) vector were inoculated into the right footpad of each mouse. When the tumor reached 200 mm3, the mice were visualized using the IVIS spectral imaging system; the primary tumor and popliteal LNs were removed and then analyzed by IHC using anti-LYVE-1 antibodies (Abcam, Cambridge, UK). Images were visualized under a Nikon Eclipse Ti microscope (Nikon, Japan). Original images of excised popliteal LNs from the nude mice are shown in Figure S5.
+ Open protocol
+ Expand
3

Corneal Neovascularization Induction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Corneal neovascularization in 20- to 24-weeks-old male mice by nylon suturing under microscopy was performed according to the previous study 21 (link). Under general anesthesia, 10-0 nylon suture was placed intra-stromally 1 mm away from the limbal vessel. Ofloxacin ophthalmic ointment was instilled immediately after suturing. For SDF1 neutralizing experiment, sterilized phosphate buffer saline as control or anti-SDF1 antibody (R&D systems) was administered by subconjunctival injection with 200μg/5μl/eye. Cornea and conjunctiva tissues were excised 5 days after sutured and antibody treatment, and double stained with anti-CD31 (BD Biosciences) and anti-LYVE-1 antibodies (Abcam).
+ Open protocol
+ Expand
4

Corneal Immunostaining and Flat Mounting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Corneal immunostaining and flat mounting was performed as previously described.29 (link) Briefly, enucleated eyes were fixed in 4% paraformaldehyde (PFA) for one hour at room temperature, rinsed in PBS, and cut in half. The iris was removed from the cornea and the cornea was cut radially to facilitate flat mounting. The corneas were placed in 100% methanol at −20°C overnight before immunostaining.
To detect blood and lymphatic vessels in flat-mount immunostaining, the corneas were permeabilized with 1% Triton X-100/PBS for 20 minute, and blocked with 5% donkey serum (Sigma) for 20 minute, and then stained with anti-Lyve-1 antibodies (Abcam) overnight at 4°C. Corneas were then washed with 0.1% Tween 20/PBS and then stained with PE-conjugated anti-CD31 (BD Biosciences, clone MEC 13.3) and AlexaFluor488 donkey anti-rabbit IgG (Invitrogen). Corneas were flat mounted and images were collected by a Zeiss Axio Observer D1 at 2.5X.
+ Open protocol
+ Expand
5

Monitoring Gastric Cancer Tumor Growth with Kallistatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gastric cancer cell line HGC-27 (2 × 10 6 ) previously infected by pLenti-CMV-EGFP-linker-Luc-PGK-Puro (OBiO Biotech, Shanghai, China) was inoculated into the foot-pads of the two groups of mice (each containing 10 mice) on day 0. When the tumors in the foot-pads reached a volume of ~100 mm 3 , they were imaged with the IVIS Spectrum Imaging System (Perkin Elmer) after injection of luciferin (Promega), and mice were then randomized into two groups. The rKAL-treated group received an intraperitoneal injection of recombinant kallistatin at 48-h intervals to a total amount of 2.88 mg/kg body mass rKAL; the control group was treated with the same volume of phosphate-buffered saline. Tumor growth was monitored by external measurement in two dimensions. Tumor volume was calculated by the following formula: volume (mm 3 ) = (length × width 2 )/2. 28 days after the first injection, tumors in the foot-pads and popliteal lymph nodes were imaged with the IVIS Spectrum Imaging System. The mice were then killed and tumors were dissected and weighed. Last, tumors and popliteal lymph nodes were enucleated and embedded in paraffin. Serial 5-μm sections were analyzed by green fluorescent protein (GFP) imaging and immunohistochemistry (IHC) with anti-LYVE-1 antibodies (Abcam, Cambridge, MA, USA). The images were captured using an AxioVision Rel.4.6 system (Carl Zeiss, Jena, Germany).
+ Open protocol
+ Expand
6

Immunohistochemical Evaluation of Lymphatic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Consecutive 3 μm sections were cut from each block, and immunohistochemistry was performed as we described previously. An immunoperoxidase technique was done following antigen retrieval with microwave treatment (95°C) in citrate buffer (pH 6.0) for 45 min. After endogenous peroxidase block by 3% H2O2-methanol for 15 min, specimens were rinsed with phosphate-buffered saline (PBS) three times. Anti-Prox1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-FOXC2 antibody (Santa Cruz Biotechnology), anti-CD34 antibody (a marker for vascular endothelial cells) (DAKO, Carpinteria, CA, USA), and anti-LYVE-1 antibody (a marker for lymphovascular endothelial cells) (Abcam, Tokyo, Japan) diluted by 0.5 μg/ml were used for primary antibody. After 2 h incubated at room temperature, specimens were rinsed with PBS three times and treated for an hour at room temperature with the secondary antibody peroxidase-conjugated anti-mouse (Medical & Biological Laboratories Co., Ltd., Nagoya, Japan) diluted at 0.5%. The specimens were then rinsed with PBS three times and color-developed with diaminobenzidine (DAB) solution (DAKO). After washing, specimens were counterstained with Meyer’s-hematoxylin (Sigma Chemical Co., St. Louis, MO, USA). Immunostaining of all samples was performed at the same conditions of antibody reaction and DAB exposure.
+ Open protocol
+ Expand
7

Isolation and Analysis of Lymphatic Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells isolated from E15.5 control (Notch1flx/flx) and conditional Notch1 mutant (Notch1flx/flx;Prox1CreERT2) embryos were stained for Lyve-1 and CD31 and subjected to FACS. Briefly, E15.5 embryos were harvested in Hank’s balanced salt solution (HBSS, Sigma-Aldrich) and then chopped for an overnight digestion with collagenease I/II. The colleagenase-treated cell suspension was incubated with RBC (Red blood cell) lysis buffer (StemCell Technologies). Following centrifugation, cell pellets were incubated with anti-Lyve-1 antibody (Abcam) for 20 min at 4°C. After washing with PBS, the cells were then stained with PE-conjugated anti-CD31 antibody (BD Pharmingen) and Alexa 488-conjugated donkey anti-rabbit secondary antibody (Invitrogen). After gauze filtration with a cell strainer (40μm BD Biosciences) to obtain a single cell suspension, the cells were subjected to staining with Annexin V - APC (BD Pharmingen) to assess cell death in the sorted LECs using Flow Fortessa.
+ Open protocol
+ Expand
8

Immunofluorescence Staining of Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescence staining of tissue samples 5 µm sections of formalin-fixed and paraffin-embedded tissue blocks were used and treated, as described previously14 (link). The incubation with the anti-LYVE-1 antibody (Abcam, Cambridge; 1:100 in 2% BSA/TBS) occurred over night at 4 °C and after three washing steps with PBS the secondary antibody Alexa fluor 488 anti-rabbit (Life technologies, Carlsbad, USA; 1:500 in PBS) was added for 1 h at 37 °C. Finally, tissue sections were washed again with PBS and VECTASHIELDTM Slide Mounting Medium with DAPI (Vector Laboratories Inc., Burlingame, USA) was added for mounting. Photographic documentation was performed using the Axio Imager Zeiss Z1 microscope (Axiovision, Carl Zeiss, Oberkochen, Germany).
+ Open protocol
+ Expand
9

Lymphangiogenesis and Angiogenesis Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC-conjugated mouse anti-human CD34 and mouse IgG1 K isotype control-FITC were from eBioscience (CA, USA). APC-conjugated mouse anti-human VEGFR-3 and mouse IgG1 isotype control-APC were from R&D systems (USA). Anti-LYVE-1 antibody was from Abcam. FITC-conjugated secondary antibodies were from KeyGEN Biotechnology Company (Nanjing, China).
Ficoll-Hypaque solution was purchased from Haoyang Biotechnology Company (Tianjin, China). Goat serum and 4% paraformaldehyde were from Boster Biotechnology Company (Wuhan, China). VEGF-C and SDF-1 were from PeproTech. Lenvatinib (E7080) was from Selleckchem. AMD3100 was from Sigma-Aldrich. Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were from Hyclone. Complete growth medium EGM-2MV was from Lonza. 4′,6-Diamidino-2-phenylindole (DAPI) was from Beyotime Biotechnology Company (Shanghai, China). JFK (Lot number 130202) was obtained from Jilin Jinfukang Pharmaceutical Co., Ltd., (Jilin, China).
+ Open protocol
+ Expand
10

Tumor Angiogenesis and Lymphangiogenesis Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were fixed, embedded in paraffin and sectioned into 4-μm thick. After deparaffinization and rehydration, sections were blocked and then incubated with anti-CD31 antibody (1:50) (Abcam, MA, USA), anti-LYVE1 antibody (1:200) (Abcam, MA, USA) and anti-CD206 antibody (1:50) (Abcam, MA, USA). A biotinylated goat anti-rabbit antibody and ABC Kit were used. CD31 positive ‘hotspots’ represented blood vessels. LYVE-1 positive ‘hotspots’ represented lymphatic vessels. CD206 positive cells were considered as macrophages. Images were quantified at 40X magnification. The quantitative analysis was made on five independent fields per tumor randomly.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!